MedElevator Войти в исследования
← Поиск публикаций

DOI 10.7754/clin.lab.2022.211019

Медицинская библиотека · Clinical laboratory · 2022

Evaluation of the Prognostic Significance of Cereblon Protein Expression in Multiple Myeloma.

Kahraman Dudu S, Diniz Gulden, Ceylan Cengiz, Guler Demircan, Sayhan Sevil, Cekdemir Demet

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Considerable progress has been made in the treatment of multiple myeloma (MM) patients with the development of various new agents that increased survival rates over the past fifteen years. Cereblon (CRBN) plays an important role in mediating the antitumor effects of immunomodulatory drugs (IMiDs) among these new agents. The aim of our study is to investigate immunohistochemically (IHC) cereblon protein expression status in MM.

METHODS

Immunohistochemically, CRBN expression and its relationship with various prognostic factors were evaluated in bone marrow biopsies of 96 patients with MM in a single centre.

RESULTS

Cytoplasmic and nuclear CRBN expression was detected in all neoplastic cells. While a complete or partial response to treatment was obtained in 45 patients, the disease was stable in 13 and progressive in 17 patients. Survival was longer in those treated with IMiD-containing regimens (p = 0.044). Both the survival rate (p = 0.013) and the survival time were significantly increased (p = 0.023) in those who received the treatment protocol containing protease inhibitors. A significant relationship was found between the treatment protocol and treatment response in the chi-squared analysis (p = 0.008). Although the longest survival time - though not statistically significant - was detected in the group treated with protease inhibitors (log rank, p = 0.217). The survival analysis revealed the presence of a relationship between IgG and IgA positivity and survival.

CONCLUSIONS

In this study, the survival time of the patients who received treatment regimens containing protease inhibitors and IMiD was longer, independent of the presence of strong nuclear CRBN expression. The survival rate was significantly higher in those who used IMiD and protease inhibitors in combination. Since the survival rate was found to be increased in IgG positive cases and we thought that evaluation of immunoglobulin tissue expression in MM cases can provide prognostic prediction.

Для цитирования: Kahraman Dudu S, Diniz Gulden, Ceylan Cengiz, Guler Demircan, Sayhan Sevil, Cekdemir Demet. Evaluation of the Prognostic Significance of Cereblon Protein Expression in Multiple Myeloma.. Clinical laboratory. 2022. DOI: 10.7754/clin.lab.2022.211019.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.